GCPEF yields 1428.57% · MRK yields 2.76%● Live data
📍 GCPEF pulled ahead of the other in Year 1
Combined, GCPEF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GCPEF + MRK for your $10,000?
GCL Technology Holdings Limited manufactures and sells polysilicon and wafers products in the People's Republic of China and internationally. It operates through three segments: Solar Material Business, Solar Farm Business, and New Energy Business. The Solar Material Business segment primarily manufactures and sells polysilicon and wafer products to companies operating in the solar industry. The Solar Farm Business segment operates and manages 18 MW solar farms located in the United States and 150 MW solar farms situated in South Africa; and 5 solar farms in the People's Republic of China. The New Energy Business segment develops, constructs, operates, and manages solar farms. The company was formerly known as GCL-Poly Energy Holdings Limited and changed its name to GCL Technology Holdings Limited in April 2022. GCL Technology Holdings Limited was incorporated in 2006 and is based in Kowloon, Hong Kong.
Full GCPEF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.